X

Xenon Pharmaceuticals
D

XENE

32.763
USD
-0.06
(-0.17%)
مغلق
حجم التداول
34,337
الربح لكل سهم
-4
العائد الربحي
-
P/E
-10
حجم السوق
2,514,022,904
أصول ذات صلة
A
AKRO
2.090
(3.90%)
55.630 USD
AMGN
AMGN
-2.10
(-0.70%)
295.22 USD
A
ARCT
-0.220
(-1.74%)
12.400 USD
BIIB
BIIB
-1.660
(-1.25%)
130.660 USD
F
FULC
0.07500
(1.11%)
6.85000 USD
GOOGL
GOOGL
-1.035
(-0.59%)
174.695 USD
المزيد
الأخبار المقالات

العنوان: Xenon Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.